Function of asthma- and allergic disease-associated risk variants and genes in lung immune cells

肺免疫细胞中哮喘和过敏性疾病相关风险变异和基因的功能

基本信息

  • 批准号:
    10261991
  • 负责人:
  • 金额:
    $ 47.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-19 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Asthma and allergic diseases (AADs) affect over 25 million children and adults in the United States, and AAD incidence has been increasing over the last 4 decades. There is significant clinical heterogeneity in AAD due to multiple overlapping but distinct underlying mechanisms of disease. Both innate and adaptive branches of the immune system play key roles in asthma pathogenesis and the heterogeneity of the disease. Yet, studies of immune cells in asthma have rely mostly on peripheral blood cells, which have different origins, composition, receptors and function than immune cells in the lung. Our work combined with those of others demonstrated that subsets of lung T cells, B cells, macrophages and dendritic cells have substantial differences from their counterparts in blood and other tissues. Thus, circulating immune cells are a poor model for tissue-based immune cells, and focus should shift toward lung-resident immune cells in studies of AADs. In Project 2, we focus on discovering mechanisms that guide the function of specific lung-resident immune cells and how genetic variation perturbs these mechanisms. The premise that most AAD-associated genetic variants impart their effects by changing the properties of cell type-specific regulatory elements thereby altering expression of target genes, implies that the phenotypic effects of these variants should be studied in homogenous populations of specific lung cells. Nevertheless, the largest public expression quantitative trait loci (eQTL) databases, such as GTEx, sample whole lung, which represents a mix of many different cell types. Nearly all that is known about genetic effects in immune cells are from studies of peripheral blood immune cells. As such, extrapolation of the effects of AAD risk variants from these resources are not likely to reflect their effects in AAD-relevant lung immune cells. Thus, our overall goal is to address these significant gaps by leveraging this collaborative program's unique resources to determine i) how specific lung immune cell types relevant to AADs contribute to immune responses, ii) the effects of genetic variation on these responses, iii) how different lung immune cell types coordinate to generate immune responses and how this is skewed by AAD-relevant inflammatory states, and iv) the functional effects on AAD causal variants and their target genes. We will achieve our goals through 3 Aims. Aim 1 will use human lymphoid and myeloid lung-resident immune cells to determine the landscape of stimulation-responsive genes, enhancers and stimulation-responsive chromatin and the effects of genetic variation on these responses. Aim 2 will determine how putative causal variants affect gene expression and downstream function in lung immune cells under asthma relevant conditions. Aim 3 will investigate the role of genetic variation identified through our omics studies on the in vivo response to allergic stimulation using CRISPR and BAC transgenic technology. Achieving our goals will link cells-specific mechanisms of immune regulation, genetic risk in AAD and specific genes, ultimately leading to treatments for asthma and allergic diseases.
哮喘和过敏性疾病(AAD)在美国影响着超过2500万儿童和成人,AAD 在过去的40年里,发病率一直在上升。AAD具有显著的临床异质性,其原因是 多种重叠但不同的潜在疾病机制。既有先天的也有适应性的 免疫系统在哮喘的发病机制和疾病的异质性中起着关键作用。然而,对生物多样性的研究 哮喘的免疫细胞主要依赖于外周血细胞,外周血细胞具有不同的来源、组成 受体和功能比肺中的免疫细胞更多。我们的工作与其他人的工作相结合证明了 肺T细胞、B细胞、巨噬细胞和树突状细胞亚群与其 血液和其他组织中的对应物。因此,循环免疫细胞不是以组织为基础的模型 在对AADS的研究中,应将重点转移到肺部驻留的免疫细胞。在项目2中,我们 专注于发现引导特定肺部常驻免疫细胞功能的机制以及如何 基因变异扰乱了这些机制。大多数与AAD相关的基因变异传递的前提是 它们通过改变细胞类型特定的调控元件的属性从而改变其表达而发挥作用 靶基因,意味着这些变异的表型效应应该在同源基因中研究。 特定的肺细胞群。然而,最大的公共表达数量性状基因座(EQTL) 数据库,如GTEx,采样整个肺,这代表了许多不同类型的细胞的混合。几乎所有人 已知的关于免疫细胞遗传效应的研究来自于对外周血液免疫细胞的研究。因此, 从这些资源中推断AAD风险变量的影响不太可能反映它们的影响 与AAD相关的肺免疫细胞。因此,我们的总体目标是通过利用这一点来解决这些重大差距 协作计划的独特资源,以确定i)特定的肺免疫细胞类型与AADS的相关性 对免疫反应的贡献,II)遗传变异对这些反应的影响,III)不同的肺 免疫细胞类型协调以产生免疫反应,以及AAD相关因素对免疫反应的影响 炎症状态,以及iv)对AAD因果变体及其靶基因的功能影响。我们会 通过三个目标实现我们的目标。AIM 1将使用人类淋巴和髓系肺常驻免疫细胞来 确定刺激反应基因、增强子和刺激反应染色质的图景 以及遗传变异对这些反应的影响。目标2将确定推定的因果变量如何 影响哮喘相关条件下肺免疫细胞的基因表达和下游功能。目标 3将研究通过我们的组学研究确定的遗传变异在体内对 使用CRISPR和BAC转基因技术进行过敏刺激。实现我们的目标将链接特定于细胞的 免疫调节机制、AAD的遗传风险和特定基因,最终导致治疗 哮喘和过敏性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anne I. Sperling其他文献

Exopolysaccharide-treated Dendritic Cells Effectively Ameliorate Acute Graft vs Host Disease.
胞外多糖处理的树突状细胞可有效改善急性移植物抗宿主病。
  • DOI:
    10.1016/j.jtct.2023.10.023
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    O. Kalinina;L. Minter;Anne I. Sperling;M. K. Hollinger;Phong Le;Barbara A. Osborne;Shubin Zhang;Patrick Stiff;Katherine L. Knight
  • 通讯作者:
    Katherine L. Knight
Lung cDC1 and cDC2 dendritic cells priming naive CD8sup+/sup T cells emin situ/em prior to migration to draining lymph nodes
肺 cDC1 和 cDC2 树突状细胞在迁移至引流淋巴结之前原位初始 CD8+T 细胞的启动
  • DOI:
    10.1016/j.celrep.2023.113299
  • 发表时间:
    2023-10-31
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Youhui Si;Yihan Wang;Qiaomu Tian;Qiang Wang;Jared M. Pollard;Pramod K. Srivastava;Aaron P. Esser-Kahn;Joel H. Collier;Anne I. Sperling;Anita S. Chong
  • 通讯作者:
    Anita S. Chong
Integration of functional genomics and statistical fine-mapping systematically characterizes adult-onset and childhood-onset asthma genetic associations
  • DOI:
    10.1186/s13073-025-01459-z
  • 发表时间:
    2025-04-10
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Xiaoyuan Zhong;Robert Mitchell;Christine Billstrand;Emma E. Thompson;Noboru J. Sakabe;Ivy Aneas;Isabella M. Salamone;Jing Gu;Anne I. Sperling;Nathan Schoettler;Marcelo A. Nóbrega;Xin He;Carole Ober
  • 通讯作者:
    Carole Ober

Anne I. Sperling的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anne I. Sperling', 18)}}的其他基金

Function of asthma- and allergic disease-associated risk variants and genes in lung immunecells
肺免疫细胞中哮喘和过敏性疾病相关风险变异和基因的功能
  • 批准号:
    10827535
  • 财政年份:
    2021
  • 资助金额:
    $ 47.46万
  • 项目类别:
Function of asthma- and allergic disease-associated risk variants and genes in lung immune cells
肺免疫细胞中哮喘和过敏性疾病相关风险变异和基因的功能
  • 批准号:
    10453777
  • 财政年份:
    2021
  • 资助金额:
    $ 47.46万
  • 项目类别:
IRF4+ respiratory dendritic cells in type 2 inflammatory responses
IRF4呼吸树突状细胞在2型炎症反应中的作用
  • 批准号:
    9311817
  • 财政年份:
    2017
  • 资助金额:
    $ 47.46万
  • 项目类别:
Human Lung T cell subsets in Disease
疾病中的人肺 T 细胞亚群
  • 批准号:
    9169074
  • 财政年份:
    2016
  • 资助金额:
    $ 47.46万
  • 项目类别:
HLA-G effector mechanisms in asthma
哮喘中的 HLA-G 效应机制
  • 批准号:
    8691382
  • 财政年份:
    2013
  • 资助金额:
    $ 47.46万
  • 项目类别:
Lung Biological Specimens Core
肺生物标本核心
  • 批准号:
    8380132
  • 财政年份:
    2012
  • 资助金额:
    $ 47.46万
  • 项目类别:
HLA-G effector mechanisms in asthma
哮喘中的 HLA-G 效应机制
  • 批准号:
    8380125
  • 财政年份:
    2012
  • 资助金额:
    $ 47.46万
  • 项目类别:
Dendritic cell produced IL-33 in Th2 responses
树突状细胞在 Th2 反应中产生 IL-33
  • 批准号:
    8104938
  • 财政年份:
    2011
  • 资助金额:
    $ 47.46万
  • 项目类别:
HLA-G effector mechanisms in asthma
哮喘中的 HLA-G 效应机制
  • 批准号:
    8196611
  • 财政年份:
    2011
  • 资助金额:
    $ 47.46万
  • 项目类别:
Lung Biological Specimens Core
肺生物标本核心
  • 批准号:
    8196617
  • 财政年份:
    2011
  • 资助金额:
    $ 47.46万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了